• Hausa Edition
  • Podcast
  • Conferences
  • LeVogue Magazine
  • Business News
  • Print Advert Rates
  • Online Advert Rates
  • Contact Us
Tuesday, August 26, 2025
Leadership Newspapers
Read in Hausa
  • Home
  • News
  • Politics
  • Business
  • Sport
  • Health
  • Entertainment
  • Opinion
    • Editorial
  • Columns
  • Football
  • Others
    • LeVogue Magazine
    • Conferences
    • National Economy
  • Contact Us
No Result
View All Result
  • Home
  • News
  • Politics
  • Business
  • Sport
  • Health
  • Entertainment
  • Opinion
    • Editorial
  • Columns
  • Football
  • Others
    • LeVogue Magazine
    • Conferences
    • National Economy
  • Contact Us
No Result
View All Result
Leadership Newspapers
No Result
View All Result

All Hands On Deck To Tackle Hepatitis B Virus

by Royal Ibeh
3 years ago
in Columns
Hepatitis
Share on WhatsAppShare on FacebookShare on XTelegram

Experts have said vaccinating against Hepatitis Virus, (HBV) remains the single best way of vanquishing the virus.

HBV has been described as the most deadly viral diseases, claiming lives of more than 800,000 people each year.

Advertisement

It is transmitted through contact with the bodily fluids of an infected person. The virus latches onto cells in the liver, injects its DNA and hijacks the cell’s machinery to power its own replication.

“HBV is a silent assassin. It can hide out for decades, causing potentially life-threatening damage to the liver and spreading to new victims before any symptoms show,” GAVI, the vaccine alliance disclosed.

Although, there are two types of treatment for Hepatitis (One uses nucleot(s)ide analogues, molecules that block the viral DNA from replicating inside the host cells. The other involves flooding the body with proteins called interferons, which switch on the body’s natural immune defences against the virus), Professor of Molecular Virology at the Saint Louis University School of Medicine, John Tavis, said only five to 10 per cent of patients achieve a functional cure when using these treatments.

“It is great we have these therapies but it is not where we need to be. One class (of drugs) is hard to take, the other you need to take forever,” Tavis disclosed while speaking to Vaccineswork team at GAVI.

RELATED

Remembering Nigeria’s Victims Of Terror

Remembering Nigeria’s Victims Of Terror

2 days ago
Agwu Becomes Fellow Of NIPR

My Encounter With Mufu The Vulcanizer

4 days ago
ADVERTISEMENT

To reduce vertical transmission of the virus, a dose of HepB vaccination is recommended within 24 hours of birth. However, in 2021, less than 20 per cent of newborns across Africa received this birth dose of vaccination and only 14 countries in the region had national policies for HepB birth dose vaccination.

Unfortunately the coverage of Hepatitis B immunisation, though available is still not adequate in a country like Nigeria, its coverage is about 41 per cent, studies have shown.

As a result of the poor screening and low vaccination rate in Nigeria, the children born are at risk of developing chronic liver disease later in life, a recent study in Nigeria, titled: “The seroprevalence of Hepatitis B virus infection among pregnant women attending Dei-dei general hospital,” revealed.

ADVERTISEMENT

A consultant physician and gastroenterologist, Dr. Cara Cookey tells me that the world must act in urgency to eliminate Hepatitis because every 30 seconds, a person dies from hepatitis related illness even in the current COVID-19 pandemic.

On finding a cure for HBV, Tavis said the scientists all over the world are making progress in new treatments to tackle the disease.

“The feeling within the scientific community is that major improvements will happen in the next five to 10 years, but it is not going to be one optimal combination at first, it is likely going to be a collection of powerful tools that together will have the strength to take on the virus,” he said.


Join Our WhatsApp Channel

Nigerians can now earn US Dollars monthly by acquiring domains cheaply and reselling for profits up to $18,000 (nearly ₦30Million). Beneficiaries include professionals, entrepreneurs, civil servants and more. Click here to start.


Tags: Hepatitis
SendShare10196Tweet6372Share
ADVERTISEMENT
Previous Post

Kenya Elections: It’s Still Photo Finish For Odinga, Ruto

Next Post

Maimuna’s Memoir: An Annoying Incident

Royal Ibeh

Royal Ibeh

You May Like

Remembering Nigeria’s Victims Of Terror
Backpage

Remembering Nigeria’s Victims Of Terror

2025/08/25
Agwu Becomes Fellow Of NIPR
Columns

My Encounter With Mufu The Vulcanizer

2025/08/23
By-Elections And The Reality Check
Columns

By-Elections And The Reality Check

2025/08/23
Unveiling Some Jumu’ah Matters
Columns

Unveiling Some Jumu’ah Matters

2025/08/22
Putin As The President’s Medicine
Backpage

Putin As The President’s Medicine

2025/08/22
North Central At A Crossroads Of Promise
Columns

North Central At A Crossroads Of Promise

2025/08/19
Leadership Conference advertisement

LATEST

JUST-IN: NRC Suspends Abuja-Kaduna Train Services After Derailment

Fire Razes 5 House In Cross River Community

Bode George Hails PDP Zoning, Says Party Ended ‘Existential Imbecility’

JUST-IN: Tinubu Slams Temporary Ban On Raw Shea Export

UNILORIN Lecturers Stage Protest, Demand Implementation Of 2009 Agreement 

PICTORIAL: NEMA Boss Leads Rescue Mission To Site Of Abuja–Kaduna Train Derailment

FCTA Promotes 49 Deputy Directors

Derailed Train: Kaduna Gov Orders Evacuation, Treatment Of Victims

Edo Hospital Denies Complicity In Death Of Twin Babies

Delta Police Arrest Officers Caught On Video Counting Cash In Patrol Van

© 2025 Leadership Media Group - All Rights Reserved.

No Result
View All Result
  • Home
  • News
  • Politics
  • Business
  • Sport
  • Health
  • Entertainment
  • Opinion
    • Editorial
  • Columns
  • Football
  • Others
    • LeVogue Magazine
    • Conferences
    • National Economy
  • Contact Us

© 2025 Leadership Media Group - All Rights Reserved.